chr16-28477622-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001042432.2(CLN3):​c.1211A>G​(p.His404Arg) variant causes a missense change. The variant allele was found at a frequency of 0.0549 in 1,613,844 control chromosomes in the GnomAD database, including 5,394 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. H404N) has been classified as Benign.

Frequency

Genomes: 𝑓 0.11 ( 1778 hom., cov: 33)
Exomes 𝑓: 0.049 ( 3616 hom. )

Consequence

CLN3
NM_001042432.2 missense

Scores

11
6

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:13

Conservation

PhyloP100: 4.04

Publications

18 publications found
Variant links:
Genes affected
CLN3 (HGNC:2074): (CLN3 lysosomal/endosomal transmembrane protein, battenin) This gene encodes a protein that is involved in lysosomal function. Mutations in this, as well as other neuronal ceroid-lipofuscinosis (CLN) genes, cause neurodegenerative diseases commonly known as Batten disease or collectively known as neuronal ceroid lipofuscinoses (NCLs). Many alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2008]
CLN3 Gene-Disease associations (from GenCC):
  • inherited retinal dystrophy
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • neuronal ceroid lipofuscinosis
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • neuronal ceroid lipofuscinosis 3
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae), Myriad Women’s Health

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0019387603).
BP6
Variant 16-28477622-T-C is Benign according to our data. Variant chr16-28477622-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 128776.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.272 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001042432.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CLN3
NM_001042432.2
MANE Select
c.1211A>Gp.His404Arg
missense
Exon 16 of 16NP_001035897.1
CLN3
NM_000086.2
c.1211A>Gp.His404Arg
missense
Exon 15 of 15NP_000077.1
CLN3
NM_001286104.2
c.1139A>Gp.His380Arg
missense
Exon 15 of 15NP_001273033.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CLN3
ENST00000636147.2
TSL:1 MANE Select
c.1211A>Gp.His404Arg
missense
Exon 16 of 16ENSP00000490105.1
CLN3
ENST00000359984.12
TSL:1
c.1211A>Gp.His404Arg
missense
Exon 15 of 15ENSP00000353073.9
CLN3
ENST00000565316.6
TSL:1
c.1160A>Gp.His387Arg
missense
Exon 14 of 14ENSP00000456117.1

Frequencies

GnomAD3 genomes
AF:
0.113
AC:
17161
AN:
152020
Hom.:
1771
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.276
Gnomad AMI
AF:
0.0263
Gnomad AMR
AF:
0.0631
Gnomad ASJ
AF:
0.0363
Gnomad EAS
AF:
0.123
Gnomad SAS
AF:
0.159
Gnomad FIN
AF:
0.0730
Gnomad MID
AF:
0.0253
Gnomad NFE
AF:
0.0333
Gnomad OTH
AF:
0.0858
GnomAD2 exomes
AF:
0.0759
AC:
18997
AN:
250390
AF XY:
0.0749
show subpopulations
Gnomad AFR exome
AF:
0.281
Gnomad AMR exome
AF:
0.0389
Gnomad ASJ exome
AF:
0.0364
Gnomad EAS exome
AF:
0.128
Gnomad FIN exome
AF:
0.0719
Gnomad NFE exome
AF:
0.0337
Gnomad OTH exome
AF:
0.0471
GnomAD4 exome
AF:
0.0488
AC:
71386
AN:
1461706
Hom.:
3616
Cov.:
31
AF XY:
0.0513
AC XY:
37282
AN XY:
727134
show subpopulations
African (AFR)
AF:
0.283
AC:
9491
AN:
33480
American (AMR)
AF:
0.0404
AC:
1809
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0364
AC:
951
AN:
26136
East Asian (EAS)
AF:
0.0987
AC:
3918
AN:
39700
South Asian (SAS)
AF:
0.155
AC:
13346
AN:
86256
European-Finnish (FIN)
AF:
0.0655
AC:
3489
AN:
53240
Middle Eastern (MID)
AF:
0.0444
AC:
256
AN:
5766
European-Non Finnish (NFE)
AF:
0.0311
AC:
34588
AN:
1112008
Other (OTH)
AF:
0.0586
AC:
3538
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
4396
8792
13188
17584
21980
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1558
3116
4674
6232
7790
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.113
AC:
17205
AN:
152138
Hom.:
1778
Cov.:
33
AF XY:
0.116
AC XY:
8625
AN XY:
74368
show subpopulations
African (AFR)
AF:
0.276
AC:
11461
AN:
41482
American (AMR)
AF:
0.0629
AC:
962
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.0363
AC:
126
AN:
3472
East Asian (EAS)
AF:
0.123
AC:
637
AN:
5168
South Asian (SAS)
AF:
0.159
AC:
768
AN:
4828
European-Finnish (FIN)
AF:
0.0730
AC:
774
AN:
10600
Middle Eastern (MID)
AF:
0.0272
AC:
8
AN:
294
European-Non Finnish (NFE)
AF:
0.0332
AC:
2260
AN:
67984
Other (OTH)
AF:
0.0878
AC:
185
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
713
1426
2140
2853
3566
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
182
364
546
728
910
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0542
Hom.:
1972
Bravo
AF:
0.115
TwinsUK
AF:
0.0305
AC:
113
ALSPAC
AF:
0.0254
AC:
98
ESP6500AA
AF:
0.269
AC:
1180
ESP6500EA
AF:
0.0316
AC:
272
ExAC
AF:
0.0807
AC:
9797
Asia WGS
AF:
0.132
AC:
456
AN:
3478
EpiCase
AF:
0.0318
EpiControl
AF:
0.0290

ClinVar

ClinVar submissions as Germline

Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
6
not specified (6)
-
-
2
Neuronal ceroid lipofuscinosis 3 (2)
-
-
2
not provided (2)
-
-
1
Inborn genetic diseases (1)
-
-
1
Neuronal ceroid lipofuscinosis (1)
-
-
1
Neuronal Ceroid-Lipofuscinosis, Dominant/Recessive (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.25
T
BayesDel_noAF
Uncertain
0.010
CADD
Uncertain
25
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.77
D
Eigen
Uncertain
0.47
Eigen_PC
Uncertain
0.47
FATHMM_MKL
Uncertain
0.90
D
LIST_S2
Uncertain
0.90
D
MetaRNN
Benign
0.0019
T
MetaSVM
Benign
-1.3
T
MutationAssessor
Uncertain
2.0
M
PhyloP100
4.0
PrimateAI
Uncertain
0.52
T
PROVEAN
Uncertain
-2.9
D
REVEL
Uncertain
0.57
Sift
Benign
0.55
T
Sift4G
Benign
0.12
T
Polyphen
1.0
D
Vest4
0.41
MPC
0.70
ClinPred
0.017
T
GERP RS
5.0
Varity_R
0.42
gMVP
0.54
Mutation Taster
=94/6
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs77595156; hg19: chr16-28488943; COSMIC: COSV61107434; COSMIC: COSV61107434; API